Xuan Jiang

发表

Abstract 18809: PER977: A Synthetic Small Molecule Which Reverses Over-Dosage and Bleeding by the New Oral Anticoagulants

H. Masumoto, S. Bakhru, M. Grosso, 2013, Circulation.

Abstract 11395: Small Molecule Antidote for Anticoagulants

E. Mathiowitz, S. Bakhru, S. Steiner, 2012 .

Ciraparantag, an Anticoagulant Reversal Drug: Mechanism of Action, Pharmacokinetics and Reversal of Anticoagulants.

J. Ansell, S. Bakhru, Allison E. Burnett, 2020, Blood.

A Novel Whole Blood Point‐of‐Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins

S. Zappe, J. Ansell, S. Bakhru, 2019, Seminars in thrombosis and hemostasis.

Abstract 19361: Reversal of Anticoagulant-induced Bleeding in External and Internal Bleeding Models by PER977, a Small Molecule Anticoagulant Antidote

M. Mercuri, H. Masumoto, S. Bakhru, 2014 .

A synthetic small molecule antidote for anticoagulants

H. Masumoto, L. Chen, S. Bakhru, 2013 .

A new linear potentiometric titration method for the determination of deacetylation degree of chitosan

W. Zhong, Xuan Jiang, Lirong Chen, 2003 .

Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS

Lin Chen, Xuan Jiang, X. Tian, 2022, Frontiers in Pharmacology.